Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 15Breast 9Head & Neck 7Thoracic 5Sarcoma 5CNS 5Gynecologic 3Genitourinary 3Dermatologic 3Plasma cell 1Other solid neoplasm 1Other neoplasm 1Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Precancerous Conditions 1

Interventions

Whole-Body Irradiation 4Sulindac 4Peripheral Blood Stem Cell Transplantation 4Methotrexate 4fludarabine phosphate 3Selenium 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3Cetuximab 3Biopsy 3Tacrolimus 2Sirolimus 2Radiotherapy, Intensity-Modulated 2Polymerase Chain Reaction 2Oxycodone 2Mycophenolic Acid 2Melphalan 2Gene Expression Profiling 2Etoposide 2Darbepoetin alfa 2Cyclosporine 2Cyclophosphamide 2Cisplatin 2Busulfan 2Aspirin 2Aminolevulinic Acid 2Albumin-Bound Paclitaxel 2vandetanib 1soybean oil, phospholipid emulsion 1ruxolitinib 1polyphenon E 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Celecoxib × Other neoplasm × Clear all
NCT00314262 2014-10-24

Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor

Emory University

Phase 1/2 Completed
17 enrolled 7 charts
Other neoplasm

Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡